ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology

Nicholas G. Zaorsky; Anthony G. Ricco; Thomas M. Churilla; Eric M. Horwitz; Robert B. Den

doi:10.2217/fon-2016-0131

ASTRO APEx^® and RO-ILS™ are applicable to medical malpractice in radiation oncology

Nicholas G. Zaorsky, Anthony G. Ricco, Thomas M. Churilla, Eric M. Horwitz, Robert B. Den

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Aim: To analyze malpractice trials in radiation oncology and assess how ASTRO APEx^® and RO-ILS™ apply to such cases. Methods: The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes. Results: Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94). Conclusion: APEx and RO-ILS are applicable to malpractice trials in radiation oncology.

Original language	English
Pages (from-to)	2643-2657
Number of pages	15
Journal	Future Oncology
Volume	12
Issue number	22
DOIs	https://doi.org/10.2217/fon-2016-0131
State	Published - Nov 2016

Keywords

Humans
Malpractice/legislation & jurisprudence
Neoplasms/epidemiology
Radiation Oncology/legislation & jurisprudence
Radiotherapy/adverse effects

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/fon-2016-0131

Cite this

@article{3a31a79d3c05464589a65a1cc47402a3,

title = "ASTRO APEx{\textregistered} and RO-ILS{\texttrademark} are applicable to medical malpractice in radiation oncology",

abstract = "Aim: To analyze malpractice trials in radiation oncology and assess how ASTRO APEx{\textregistered} and RO-ILS{\texttrademark} apply to such cases. Methods: The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes. Results: Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94). Conclusion: APEx and RO-ILS are applicable to malpractice trials in radiation oncology.",

keywords = "Humans, Malpractice/legislation & jurisprudence, Neoplasms/epidemiology, Radiation Oncology/legislation & jurisprudence, Radiotherapy/adverse effects",

author = "Zaorsky, {Nicholas G.} and Ricco, {Anthony G.} and Churilla, {Thomas M.} and Horwitz, {Eric M.} and Den, {Robert B.}",

note = "Publisher Copyright: {\textcopyright} 2016 Future Medicine Ltd.",

year = "2016",

month = nov,

doi = "10.2217/fon-2016-0131",

language = "English",

volume = "12",

pages = "2643--2657",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "22",

}

TY - JOUR

T1 - ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology

AU - Zaorsky, Nicholas G.

AU - Ricco, Anthony G.

AU - Churilla, Thomas M.

AU - Horwitz, Eric M.

AU - Den, Robert B.

PY - 2016/11

Y1 - 2016/11

N2 - Aim: To analyze malpractice trials in radiation oncology and assess how ASTRO APEx® and RO-ILS™ apply to such cases. Methods: The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes. Results: Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94). Conclusion: APEx and RO-ILS are applicable to malpractice trials in radiation oncology.

AB - Aim: To analyze malpractice trials in radiation oncology and assess how ASTRO APEx® and RO-ILS™ apply to such cases. Methods: The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes. Results: Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94). Conclusion: APEx and RO-ILS are applicable to malpractice trials in radiation oncology.

KW - Humans

KW - Malpractice/legislation & jurisprudence

KW - Neoplasms/epidemiology

KW - Radiation Oncology/legislation & jurisprudence

KW - Radiotherapy/adverse effects

UR - http://www.scopus.com/inward/record.url?scp=84992189524&partnerID=8YFLogxK

U2 - 10.2217/fon-2016-0131

DO - 10.2217/fon-2016-0131

M3 - Review article

C2 - 27470145

AN - SCOPUS:84992189524

SN - 1479-6694

VL - 12

SP - 2643

EP - 2657

JO - Future Oncology

JF - Future Oncology

IS - 22

ER -